Cetrorelix

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Adult
State: Solid
Customization:
Gold Member Since 2023

Suppliers with verified business licenses

Trading Company

Basic Info.

HS Code
2937190090
Production Capacity
100000g/Month

Product Description

    Cetrorelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist. Cetrorelix inhibits the endogenous luteinizing hormone surge during ovarian stimulation. Cetrorelix reduces cyclophosphamide induced ovarian follicular destruction in mice.

    Product Introduction
     
    Generic name   Cetrorelix
    Formula   C70H92ClN17O14
    CAS No.   120287-85-6
    Molecular Weight    1431.04
    EINECS   686-384-6

      Chemical Properties
    Density   1.42±0.1 g/cm3(Predicted)
    Melting Point   >259°C (dec.)
    Solubility   DMSO (Slightly, Heated), Methanol (Very Slightly)
    Appearance   White to Off-White powder  
    pKa   9.82±0.15(Predicted)
    Storage Condition   Refrigerator
    Refractive Index   1.667

    Application & Efficacy

        Cetrorelix acetate is a synthetic decapeptide, which is mainly used in assisted reproductive technology to prevent premature ovulation for patients with controlled ovarian stimulation. cetrorelix acetate is also often called cetrorelix, which is a gonadotropin-releasing hormone (GnRH) antagonist, it can compete with endogenous LHRH to bind receptors on the pituitary cell membrane, thereby inhibiting the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary in a dose-dependent manner.


          

      Send your message to this supplier

      *From:
      *To:
      *Message:

      Enter between 20 to 4,000 characters.

      This is not what you are looking for? Post a Sourcing Request Now

      Find Similar Products By Category

      You Might Also Like

      Gold Member Since 2023

      Suppliers with verified business licenses

      Trading Company
      Number of Employees
      39
      Year of Establishment
      2011-02-10